Literature DB >> 15144552

Depression: a common but underrecognized condition associated with end-stage renal disease.

Pei-Li Wang1, Suzanne G Watnick.   

Abstract

We describe a patient with end-stage renal disease (ESRD) who developed depression over the period of dialysis initiation. Depression is an extremely common but underrecognized disorder in the dialysis population, which is one of the rationales for this case report. Here we present the epidemiology, mechanisms for diagnosis, associations with medical morbidity, and treatment modalities specifically for patients on dialysis.

Entities:  

Mesh:

Year:  2004        PMID: 15144552     DOI: 10.1111/j.0894-0959.2004.17313.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  4 in total

1.  Adherence barriers to chronic dialysis in the United States.

Authors:  Kevin E Chan; Ravi I Thadhani; Franklin W Maddux
Journal:  J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 10.121

2.  Indicators and correlates of psychological disturbance in Chinese patients receiving maintenance hemodialysis: a cross-sectional study.

Authors:  Si-Yuan Wang; Xiao-Ying Zang; Jun-Duo Liu; Mei Cheng; Yue-Xian Shi; Yue Zhao
Journal:  Int Urol Nephrol       Date:  2015-01-28       Impact factor: 2.370

3.  A study of sertraline in dialysis (ASSertID): a protocol for a pilot randomised controlled trial of drug treatment for depression in patients undergoing haemodialysis.

Authors:  Karin Friedli; Michael Almond; Clara Day; Joseph Chilcot; Maria da Silva Gane; Andrew Davenport; Ayman Guirguis; Naomi Fineberg; Benjamin Spencer; David Wellsted; Ken Farrington
Journal:  BMC Nephrol       Date:  2015-10-26       Impact factor: 2.388

4.  The Correlations among Depressive Symptoms, Cognitive Performance and Serum BDNF Levels in the Patients with Chronic Kidney Disease.

Authors:  Jung Goo Lee; Min Kyung Park; Yeong Hoon Kim; Yang-Wook Kim; Kyubok Jin; Sung Woo Park; Mi Kyoung Seo; Young Hoon Kim
Journal:  Psychiatry Investig       Date:  2017-10-13       Impact factor: 2.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.